香港股市 已收市

CORT Aug 2024 31.000 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
2.1900-2.2600 (-50.79%)
收市:03:57PM EDT
全螢幕
前收市價4.4500
開市2.5000
買盤1.3500
賣出價2.4500
拍板31.00
到期日2024-08-16
今日波幅2.1900 - 2.5000
合同範圍
成交量13
未平倉合約28
  • Zacks

    Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  • Reuters

    Teva sues Corcept over mifepristone 'monopoly' for rare disorder

    Teva Pharmaceuticals sued rival drugmaker Corcept Therapeutics in federal court in San Francisco on Thursday, accusing it of monopolizing the market for mifepristone-based Korlym, used to treat a rare hormonal disorder called Cushing's syndrome. The lawsuit said Corcept and specialty pharmacy Optime Care, the sole distributor of Korlym, orchestrated “a multifaceted scheme to prolong Corcept’s monopoly by stifling competition from Teva at every turn.” Teva accused Corcept of "paying bribes and kickbacks" to physicians to keep them prescribing brand Korlym.

  • Zacks

    Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?

    Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.